Neurology & Movement Disorders
Parkinson’s Disease (PD)
Parkinson’s Disease (PD) is a progressive neurological disorder that affects movement, coordination, and quality of life. CenExel partners with sponsors to advance innovative Parkinson’s treatments through specialized clinical research, experienced investigators, and patient-focused trial execution across early and late-stage studies.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Parkinson’s Disease Clinical Research
CenExel delivers comprehensive clinical research solutions for Parkinson’s Disease studies, combining scientific expertise, operational excellence, and access to diverse patient populations. Our neurology-focused teams support sponsors through every stage of development — from proof-of-concept studies to large-scale Phase IV trials.
Conditions Covered
Parkinson’s Disease Conditions We Research
Our neurology research sites support a broad range of Parkinson’s Disease and movement disorder studies, including motor and non-motor symptom management.
- Early Parkinson’s Disease
- Advanced Parkinson’s Disease
- Tremor Disorders
- Dyskinesia
- Parkinson’s Disease Dementia
- Movement Disorders
- Bradykinesia
- Sleep Disturbances in PD
Our Approach
Why Sponsors Choose CenExel for Parkinson’s Disease Research
CenExel provides scientific consultation, strong enrollment capabilities, and operational excellence to support successful Parkinson’s Disease clinical trials.
01
Neurology Expertise
Our experienced neurology investigators specialize in Parkinson’s Disease and movement disorder research.
02
Advanced Biomarker Strategy
We support biomarker-driven studies and advanced neurological assessments for better clinical insights.
03
Diverse Patient Access
Access to broad and diverse patient populations across multiple U.S. research locations.
04
High Enrollment Performance
Our recruitment strategies help accelerate enrollment and improve retention throughout the study lifecycle.
Phase Coverage
Supported Parkinson’s Disease Trial Phases
CenExel supports Parkinson’s Disease clinical research from first-in-human studies through post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our neurology-focused sites provide specialized support for movement disorder assessments, imaging, biomarker collection, and long-term patient follow-up.
Parkinson’s Disease Task Force
CenExel supports a wide range of Parkinson’s Disease and movement disorder clinical studies with experienced neurology investigators and dedicated research infrastructure.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
